Valink Therapeutics
PrivateLast Round
Seed
Oct 20, 2025
Est. Valuation
$1.79M
Total Funding Raised
$19.85M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Valink Therapeutics is a biotechnology company that develops next-generation, antibody-based therapeutics, specifically bispecific antibody-drug conjugates (bsADCs), to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valink Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Valink Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2025 | ||||
| Seed | Nov 2, 2023 | ||||
| Accelerator | Mar 24, 2021 | ||||
| Accelerator | Jan 1, 2021 |
Key People
Founding team and executive leadership
Valink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Magnet Ventures | Seed |
| Metaplanet Holdings | Seed |
| Oxford Science Enterprises | Seed |
| Acequia Capital | Seed |
| Hoxton Ventures | Seed |
| Oxonian Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Partnered with Nona Biosciences for integrated drug discovery solutions.
- Oct 20, 2025
$12M raised in early funding.
Valink Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Valink Therapeutics's valuation, stock price, and market status.